商業快報

Jab for obese adults set to become easier to obtain through NHS
英國肥胖症患者將更容易通過NHS獲得新藥索馬魯肽

Semaglutide should be made more accessible to help patients and relieve pressure on hospitals, say ministers
英國的大臣們表示,應該讓人們更容易獲得索馬魯肽,以幫助肥胖症患者治療並減輕醫院的壓力。
Rishi Sunak visiting staff at a primary care surgery in Southampton. ‘Using the latest drugs to support people to lose weight will be a game-changer,’ he says

A new jab that can help obese adults lose 15 per cent of their body weight is set to be made more widely available on the NHS, after the government announced it was exploring ways for patients to receive it without having to go to hospital.

一種可以幫助肥胖成年人減掉15%體重的新針劑將在英國國家醫療服務體系(NHS)得到更廣泛的普及,先前英國政府宣佈,正在探索讓患者無需去醫院就能接種這種針劑的方法。

您已閱讀11%(479字),剩餘89%(3736字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×